Table 3:
Risk of any event | Risk of suicide | Risk of overdose | Risk of Adverse events | Buprenorphine Filled | |
---|---|---|---|---|---|
aHR (95% CI)* | aHR (95% CI)* | aHR (95% CI)* | aHR (95% CI)* | aOR (95% CI)* | |
Stable or increasing dose | Reference | Reference | Reference | Reference | Reference |
Abrupt discontinuation | 1.22 (0.94–1.58) | 3.63 (1.42–9.25) | 0.62 (0.40–0.94) | 1.61 (1.15–2.26) | 15.07 (7.28–38.38) |
Dose reduction and discontinuation | 1.13 (0.84–1.53) | 4.47 (1.68–11.88) | 0.36 (0.20–0.66) | 1.54 (1.05–2.25) | 14.83 (7.00–38.33) |
Dose reduction without discontinuation | 0.94 (0.73–1.21) | 1.29 (0.48–3.45) | 0.41 (0.27–0.62) | 1.45 (1.04–2.02) | 2.47 (1.14–6.46) |
aHR: adjusted hazard ratio; OR: odds ratio, CI: confidence interval
Adjusted for age, gender, race, rurality, comorbidities, MME dose, filled benzodiazepines, chronic pain